Biotech

All Articles

Viridian eye condition phase 3 smash hits, evolving push to rival Amgen

.Viridian Therapeutics' stage 3 thyroid eye health condition (TED) medical trial has reached its mai...

Bain reveals $3B fund permanently science business

.With a powerful record for pinpointing rough diamonds, Bain Funding Everyday Life Sciences (BCLS) h...

Genentech's cancer restructure created 'for scientific explanations'

.The latest choice to combine Genentech's 2 cancer cells teams was created "clinical causes," manage...

Tern dental GLP-1 presents 5% fat burning at 1 month at greatest dose

.Terns Pharmaceuticals' selection to drop its own liver disease ambitions might yet pay off, after t...

Merck, Daiichi loyal early excellence in small mobile bronchi cancer along with improved ADC information

.Merck &amp Co.'s long-running effort to land a strike on tiny cell lung cancer cells (SCLC) has act...

Boehringer, Bayer innovation bronchi cancer cells drugs toward Astra war

.Some people along with non-small tissue lung cancer cells (NSCLC) have mutations in a gene referred...

MBX aims for $136M IPO to take opponent to Ascendis into period 3

.MBX has actually fleshed out strategies to enjoy over $136 thousand from its IPO as the biotech see...

Relay breast cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has hammered its own survival objective in a first-in-human bosom cancer cells r...

AZ lays out AI-enabled TROP2 biomarker tactic for Daiichi ADC

.AstraZeneca has utilized artificial intelligence to create a distinct biomarker for its own Daiichi...

AstraZeneca IL-33 drug fails to improve COPD breathing in ph. 2

.AstraZeneca executives say they are actually "not stressed" that the breakdown of tozorakimab in a ...